TY - STD TI - FDA approves Nucala to treat severe asthma. US Food and Drug Administration: US Department of Health and Human Services; 2015. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm471031.htm. Accessed 10 Sept 2016. UR - http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm471031.htm ID - ref1 ER - TY - JOUR AU - Bel, E. AU - Wenzel, S. AU - Thompson, P. AU - Prazma, C. AU - Keene, O. AU - Yancey, S. PY - 2014 DA - 2014// TI - Oral glucocorticoid-sparing effect of Mepolizumab in eosinophilic asthma JO - N Engl J Med VL - 371 UR - https://doi.org/10.1056/NEJMoa1403291 DO - 10.1056/NEJMoa1403291 ID - Bel2014 ER - TY - JOUR AU - Nair, P. AU - Pizzichini, M. AU - Kjarsgaard, M. PY - 2009 DA - 2009// TI - Mepolizumab for prednisone-dependent asthma with sputum eosinophilia JO - N Engl J Med VL - 360 UR - https://doi.org/10.1056/NEJMoa0805435 DO - 10.1056/NEJMoa0805435 ID - Nair2009 ER - TY - JOUR AU - Finkelman, F. D. AU - Madden, K. B. AU - Morris, S. C. AU - Holmes, J. M. AU - Boiani, N. AU - Katona, I. M. PY - 1993 DA - 1993// TI - Anti-cytokine antibodies as carrier proteins. Prolongation of in vivo effects of exogenous cytokines by injection of cytokine-anti-cytokine antibody complexes JO - J Immunol VL - 151 ID - Finkelman1993 ER - TY - JOUR AU - Smith, S. G. AU - Chen, R. AU - Kjarsgaard, M. AU - Huang, C. AU - Oliveria, J. P. AU - O’Byrne, P. M. PY - 2016 DA - 2016// TI - Increased numbers of activated group 2 innate lymphoid cells in the airways of patients with severe asthma and persistent airway eosinophilia JO - J Allergy Clin Immunol. VL - 137 UR - https://doi.org/10.1016/j.jaci.2015.05.037 DO - 10.1016/j.jaci.2015.05.037 ID - Smith2016 ER - TY - JOUR AU - Wilson, M. S. AU - Pesce, J. T. AU - Ramalingam, T. R. AU - Thompson, R. W. AU - Cheever, A. AU - Wynn, T. A. PY - 2008 DA - 2008// TI - Suppression of murine allergic airway disease by IL-2: anti-IL-2 monoclonal antibody-induced regulatory t cells JO - J Immunol VL - 181 UR - https://doi.org/10.4049/jimmunol.181.10.6942 DO - 10.4049/jimmunol.181.10.6942 ID - Wilson2008 ER - TY - JOUR AU - Sato, T. A. AU - Widmer, M. B. AU - Finkelman, F. D. AU - Madani, H. AU - Jacobs, C. A. AU - Grabstein, K. H. PY - 1993 DA - 1993// TI - Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo JO - J Immunol VL - 150 ID - Sato1993 ER - TY - JOUR AU - Martens, E. AU - Dillen, C. AU - Heremans, H. AU - Damme, J. V. AU - Billiau, A. PY - 1993 DA - 1993// TI - Increased circulating interleukin-6 (IL-6) activity in endotoxin-challenged mice pretreated with anti-IL-6 antibody is due to IL-6 accumulated in antigen-antibody complexes JO - Eur J Immunol VL - 23 UR - https://doi.org/10.1002/eji.1830230846 DO - 10.1002/eji.1830230846 ID - Martens1993 ER - TY - JOUR AU - Martin, C. E. AU - Leeuwen, E. M. M. AU - Im, S. J. AU - Roopenian, D. C. AU - Sung, Y. -. C. AU - Surh, C. D. PY - 2013 DA - 2013// TI - IL-7/anti–IL-7 mAb complexes augment cytokine potency in mice through association with IgG-Fc and by competition with IL-7R JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-08-449215 DO - 10.1182/blood-2012-08-449215 ID - Martin2013 ER - TY - JOUR AU - Gool, F. AU - Molofsky, A. B. AU - Morar, M. M. AU - Rosenzwajg, M. AU - Liang, H. -. E. AU - Klatzmann, D. PY - 2014 DA - 2014// TI - Interleukin-5-producing group 2 innate lymphoid cells control eosinophilia induced by interleukin-2 therapy JO - Blood VL - 124 UR - https://doi.org/10.1182/blood-2014-07-587493 DO - 10.1182/blood-2014-07-587493 ID - Gool2014 ER - TY - JOUR AU - Tjota, M. Y. AU - Williams, J. W. AU - Lu, T. AU - Clay, B. S. AU - Byrd, T. AU - Hrusch, C. L. PY - 2013 DA - 2013// TI - IL-33-dependent induction of allergic lung inflammation by FcγRIII signaling JO - J Clin Investig VL - 123 UR - https://doi.org/10.1172/JCI63802 DO - 10.1172/JCI63802 ID - Tjota2013 ER - TY - JOUR AU - Tran, G. T. AU - Hodgkinson, S. J. AU - Carter, N. M. AU - Verma, N. D. AU - Plain, K. M. AU - Boyd, R. PY - 2012 DA - 2012// TI - IL-5 promotes induction of antigen-specific CD4+ CD25+ T regulatory cells that suppress autoimmunity JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2011-12-396101 DO - 10.1182/blood-2011-12-396101 ID - Tran2012 ER - TY - JOUR AU - Mukherjee, M. AU - Bulir, D. AU - Radford, K. AU - Helpard, B. AU - Kjarsgaard, M. AU - Jacobsen, E. A. PY - 2016 DA - 2016// TI - Pathogenic autoantibodies in patients with severe asthma and sputum eosinophils JO - J Allergy Clin Immunol VL - 137 UR - https://doi.org/10.1016/j.jaci.2015.12.1267 DO - 10.1016/j.jaci.2015.12.1267 ID - Mukherjee2016 ER - TY - JOUR AU - Kasjanski, R. AU - Kato, A. AU - Poposki, J. A. AU - Bochner, B. S. AU - Cao, Y. AU - Norton, J. E. PY - 2016 DA - 2016// TI - Group 2 innate lymphoid cells directly induce b cell activation in humans JO - J Allergy Clin Immunol VL - 137 UR - https://doi.org/10.1016/j.jaci.2015.12.003 DO - 10.1016/j.jaci.2015.12.003 ID - Kasjanski2016 ER - TY - JOUR AU - Weiler, C. R. AU - Kita, H. AU - Hukee, M. AU - Gleich, G. J. PY - 1996 DA - 1996// TI - Eosinophil viability during immunoglobulin-induced degranulation JO - J Leukoc Biol VL - 60 ID - Weiler1996 ER - TY - JOUR AU - Walford, H. H. AU - Lund, S. J. AU - Baum, R. E. AU - White, A. A. AU - Bergeron, C. M. AU - Husseman, J. PY - 2014 DA - 2014// TI - Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness JO - Clin Immunol VL - 155 UR - https://doi.org/10.1016/j.clim.2014.09.007 DO - 10.1016/j.clim.2014.09.007 ID - Walford2014 ER -